International Edition
Latest News
Technology

EU Regulations Risk Holding Back Engineered Living Materials Development

European regulations risk holding back development of engineered living materials as companies struggle to determine which approval procedures apply to products containing living organisms, according to a report published in 2026. Materials known as engineered living materials (ELMs)…

European regulations risk holding back development of engineered living materials as companies struggle to determine which approval procedures apply to products containing living organisms, according to a report published in 2026.

Materials known as engineered living materials (ELMs) integrate living components like bacteria, fungi, or yeast to execute specialized tasks. Such living components are capable of synthesizing compounds, reacting to environmental cues, or assisting in the self-repair of the substrate. Some organisms naturally possess properties that researchers can put to use. For example, certain bacteria produce cellulose, a substance that can be used to make clothing and textiles. Researchers can also genetically modify microorganisms to give them new functions. Among the initiatives currently underway is the European research project NextSkins, where investigators are working on a living bandage designed to identify and manage eczema.

The bandage mimics several functions of human skin, including sensing and repair.

Researchers Kai P. Purnhagen and Justus Wesseler examined the legal landscape for these materials in Law and Economics of Regulation of Engineered Living Materials in the EU, published in SpringerBriefs in Law.

Uncertainty affects projects across the continent, including the NextSkins initiative developing a living bandage capable of detecting and treating eczema.

Another project, Fungateria, combines fungal networks with modified bacteria to create biodegradable disposable slippers and insulation panels that capture carbon dioxide.

Products combining living organisms with manufactured items create complex legal questions under existing genetically modified organism rules.

Under EU regulations, materials containing modified organisms must demonstrate sufficient containment to prevent environmental escape, a standard difficult to apply to bricks or bandages that undergo wear and tear during normal use.

“[T]o qualify as ‘contained use’ under EU regulations, it must be demonstrated that the microorganisms remain sufficiently contained,” Justus Wesseler explains.

“But how can you demonstrate this for a material that may become damaged during use? And which regulations apply if the bacteria can escape after all?”

Products applied directly to human skin, such as living bandages, face overlapping classifications as medicinal products, medical devices, or genetically modified organisms.

Uncertainty also surrounds long-term liability if a living material causes unexpected biological effects over time.

“Who would be liable for the resulting damage?” Wesseler asks. “The producer of the living material, the manufacturer that incorporated it into a food product or the company selling the final product?”

Lengthy approval processes and unclear legal pathways prompt companies to delay investments or move development outside Europe.

The authors argue that European regulations should align better with the specific properties of engineered living materials rather than focusing solely on the modification technique.

They suggest creating a dedicated European body to guide companies through approval applications and improve cooperation between the European Food Safety Authority and the European Medicines Agency.

“[A] European body could help companies prepare their applications for regulatory approval,” Wesseler says.

“This would give companies a clearer understanding of what to expect and which regulations apply to their products. At the same time, it could help bring new products to market more quickly.”

About the author: Technology Desk

Technology Desk at Archynewsy.